Evaluation of Online Tool (E-TOOL SCS) in Spinal Cord Stimulaion
Launched by ISTITUTI CLINICI SCIENTIFICI MAUGERI SPA · Jan 25, 2024
Trial Information
Current as of September 16, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is an observational, prospective study in two Italian pain centers that is testing an online tool (the SCS-e-tool) to help doctors decide who might benefit from spinal cord stimulation (SCS) for chronic pain. It focuses on four conditions linked to chronic pain: Failed Back Surgery Syndrome, Complex Regional Pain Syndrome, other neuropathic pain, and ischemic limb pain. About 60 adults will be enrolled over about a year, with follow-up for up to about one year after a trial SCS implantation. The study uses routine clinical care and does not replace standard medical or psychological evaluations.
Eligible participants are adults roughly 18 to 85 years old who have chronic pain and are being considered for a temporary SCS trial, and who can give informed consent. Exclusions include those who can’t follow the study, pregnant individuals, or any contraindications to implantation. Participants will receive the usual evaluations and SCS trial as part of standard care, plus use of the e-tool. They’ll be asked about pain levels (0–10), disability in daily life, quality of life, and overall change over time at key points (trial, 6 months, and 12 months). The study looks mainly at how often the doctor’s judgment and the e-tool agree on suitability, and how well the e-tool predicts successful outcomes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Males and females aged between 18 and 85 years.
- • Patients with chronic pain and indication for implantation of a temporary neurostimulator for spinal cord stimulation testing.
- • Signed informed consent.
- Exclusion Criteria:
- • • Patients who, in the researcher's judgment, are unable to follow the protocol instructions.
- • Patients in presumed/confirmed pregnancy.
- • Contraindications to implantation.
About Istituti Clinici Scientifici Maugeri Spa
Istituti Clinici Scientifici Maugeri S.p.A. is a prestigious Italian healthcare organization dedicated to advancing medical research and clinical practice. With a strong focus on patient-centered care, the institution integrates innovative clinical trials into its comprehensive services, fostering collaboration between researchers and healthcare professionals. Known for its commitment to high-quality standards and ethical practices, Istituti Clinici Scientifici Maugeri S.p.A. plays a pivotal role in the development of new therapies and treatment modalities, contributing significantly to the global medical community and enhancing patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pavia, Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported